z-logo
open-access-imgOpen Access
Construction of a Phenylboronic Acid-Functionalized Nano-Prodrug for pH-Responsive Emodin Delivery and Antibacterial Activity
Author(s) -
Guodong Zheng,
Jiaojiao Zheng,
Le Xiao,
Tongyi Shang,
Yanjun Cai,
Yuwei Li,
Yiming Xu,
Xiaoming Chen,
Yun Liu,
Bin Yang
Publication year - 2021
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.1c00606
Subject(s) - prodrug , phenylboronic acid , hela , chemistry , drug delivery , dynamic light scattering , mtt assay , emodin , combinatorial chemistry , nuclear chemistry , in vitro , nanoparticle , organic chemistry , chromatography , biochemistry , nanotechnology , materials science , catalysis
In this study, a pH-responsive nano-prodrug was fabricated by conjugating emodin to the PEGylated polyethyleneimine (mPEG-PEI) with acid-sensitive boronate ester bonds. 1 H NMR spectra results showed that emodin was effectively bonded to mPEG-PEI, and acid-sensitive assay further confirmed the formation of boronate ester bonds. The size and morphology of the nano-prodrug were ascertained through transmission electron microscopy (TEM) and dynamic light scattering (DLS), which showed that the prodrug has a sphere-like shape with hydrodynamic size around 102 nm at pH 7.4. Subsequently, a drug-release behavior assay was carried out to carefully investigate the acid-sensitive drug-delivery property of the prodrug. Moreover, in vitro cell viability assay confirmed the superior cytotoxic effect of the nano-prodrug against HeLa cells compared to free emodin. Furthermore, the antibacterial study showed that the nano-prodrug could inhibit the bacterial (both Gram-positive and Gram-negative) growth more effectively than free emodin. Overall, this study provides a promising paradigm of the multifunctional nano-prodrug for pH-responsive tumor therapy and antibacterial activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here